Filter
88
Filtered Results: 88
Text search:
visceral
leishmaniasis
(VL)
Featured
Recommendations
5
New Publications
11
Language
Document type
No document type
24
Studies & Reports
16
Videos
11
Resource Platforms
10
Guidelines
7
Fact sheets
6
Strategic & Response Plan
5
Manuals
4
Infographics
3
Training Material
2
Countries / Regions
Global
31
Latin America and the Carribbean
7
Nepal
6
Ethiopia
6
Kenya
5
Bangladesh
4
India
4
Brazil
3
Sudan
3
Middle East and North Africa
2
South–East Asia Region
2
Western and Central Europe
2
Paraguay
2
South Sudan
2
Somalia
2
North Macedonia
1
Colombia
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Malawi
1
Morocco
1
Africa
1
Cambodia
1
Asia
1
Jordan
1
Saudi Arabia
1
Tunisia
1
East and Southern Africa
1
Bolivia
1
Lebanon
1
Uganda
1
Eastern Europe
1
Greece
1
Georgia
1
Iraq
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
27
Clinical Guidelines
15
Public Health
5
Pharmacy & Technologies
2
Women & Child Health
1
Toolboxes
NTDs
56
HIV
5
COVID-19
1
Planetary Health
1
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
During the Programme Managers’ Review Meeting of Central and East Africa and South-East Asia (online meeting, June 2022), experts proposed additional regional and national subtargets related to VL incidence, as defined below. These targets can be revisited as progress is reviewed and access to dia...
We developed an integrated vector surveillance (IVS) proposal for cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) in the Americas, based on eco-epidemiological studies conducted by researchers of the Leishmaniasis Research Network of Argentina. For CL, the transmission was explained in ...
Leishmaniasis is a vector-borne disease with a broad global distribution and an increasing number of recorded cases worldwide. However, it is still one of the world's most neglected diseases. Over the last decades, the disease has been found to expand geographically with a global increase of cases o...
The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with...
Website last accessed on 04.06.2023
Youtube Video
Website last accessed on 04.06.2023
Youtube Video
Video last accessed on 04.06.2023
Video Dailymotion
Frequently Asked Questions on Visceral Leishmaniasis
Kala-azar (Visceral leishmaniasis),PKDL:Epidemiology,clinical features, investigations and treatment
Last accessed on 14.05.2023
Youtube - Video
There are 3 main forms of leishmaniases: visceral (the most serious form because it is almost always fatal without treatment), cutaneous (the most common, usually causing skin ulcers), and mucocutaneous (affecting mouth, nose and throat).
Leishmaniasis is caused by protozoan parasites which are tra...
Website last accessed on 04.06.2023
Treatment options for Visceral Leishmaniasis in HIV-coinfected people include oral miltefosine; find additional information on diagnosis and ART treatment.
Leishmaniasis is a vector-borne tropical/subtropical disease caused by an intracellular parasite transmitted to humans by sand fly bite. It is endemic in Asia, Africa, the Americas, and the Mediterranean region. Worldwide reports include 1.5–2 million new cases each year, more than 300 million at ...
Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of infected sand flies. There are several different forms of leishmaniasis in people. The most com...
In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interacti...
Website last accessed on 04.06.2023
Bites of infected female sand flies causes the disease. The visceral form attacks internal organs; the cutaneous form causes facial ulcers, disfiguring scars and disability. #BeatNTDs
No vaccines or drugs to prevent infection are available. The best way for travelers to prevent infection is to protect themselves from sand fly bites. To decrease the risk of being bitten, follow these preventive measures:
Avoid outdoor activities, especially from dusk to dawn, when sand flies ge...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
High prevalence of target diseases in rural and developing nations, increased prevalence of malnutrition across the globe, lack of hygiene and poor sanitation facilities, Migratory patterns of population, introduction of new chemical entity in the field of therapeutics, favorable government regulati...
